Cefixime, one of the new third generation oral cephalosporin antibiotic, was evaluated for safety and efficacy in the treatment of 37 patients with non-tuberculous . Cefixime was given to 20 patients with , 10 patients with and 7 patients with infected . Each patient had before and after therapy a…